tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY
US Market

Santen Pharmaceutical Co (SNPHY) Stock News & Sentiment

Compare
6 Followers
Santen Pharmaceutical’s Promising Phase III Glaucoma Study: A Market Game-Changer?
Premium
Company Announcements
Santen Pharmaceutical’s Promising Phase III Glaucoma Study: A Market Game-Changer?
2M ago
Santen Pharmaceutical (($SNPHY)) announced an update on their ongoing clinical study. Study Overview: Santen Pharmaceutical is conducting a Phase III study titled A Phase III Study Including a Single-Arm, Open-Label, ...Read more
Santen Pharmaceutical’s Phase III Study on STN1013800: A Potential Game-Changer for Acquired Blepharoptosis Treatment in China
Premium
Company Announcements
Santen Pharmaceutical’s Phase III Study on STN1013800: A Potential Game-Changer for Acquired Blepharoptosis Treatment in China
2M ago

News Score - Last 7 Days

Neutral
SNPHY
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNPHY’s Media Buzz Sentiment?
1 articles about SNPHY were published this week. In an average week, 1 articles are published.
    What is SNPHY’s weekly average amount of articles?
    In an average week, 1 articles about SNPHY are published.
      What is SNPHY’s News Sentiment?
      50% of articles about SNPHY were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        DVAXDynavax
        AGIOAgios Pharma
        ADUSAddus Homecare
        PDEXPro-Dex
        ENSGThe Ensign Group
        Showing the stocks with the most bullish news sentiment over the past week